Seven Bridges & e-NIOS Partnership to Break the Biomarker Bottleneck

September 11, 2018 Cambridge, Mass. and Athens, Greece., Sept 11, 2018. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine... Read more

Seven Bridges announces the launch of largest pediatric data resource as a member of the Gabriella Miller Kids First Data Resource Center

September 10, 2018 Cambridge, Mass. Sept 10, 2018. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource... Read more

Seven Bridges becomes a Google Cloud Technology Partner to support life science researchers

CAMBRIDGE, Mass., May 15, 2018 /PRNewswire/ — Seven Bridges Genomics Inc., a leading biomedical data platform and analytics company, today announced it has become a certified Google Cloud Technology Partner.  The Seven Bridges Platform deployment on Google Cloud offers researchers confronted with the myriad challenges of big data bioinformatics an end-to-end solution to accelerate data processing and... Read more

Elsevier and Seven Bridges Receive NIH Data Commons Grant for Biomedical Data Analysis

Project to improve biomedical data efficiency and reliability NEW YORK, November 7, 2017 /PRNewswire/ — Elsevier and Seven Bridges Genomics announced today that The National Institutes of Health (NIH) has awarded them a grant for the development of a comprehensive, open-source data analysis ecosystem as part of its Data Commons Pilot Phase. The project is designed to improve data efficiency and reliability for... Read more

Seven Bridges Leads Public-Private Partnership to Develop New Data Ecosystem for NIH

November 6, 2017 Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass., November 06, 2017 – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support... Read more

The Jackson Laboratory and Seven Bridges Collaborate to Build Centralized Data Platform to Advance Cancer Research

October 17, 2017 National Cancer Institute awards $2M grant to fund joint PDX data center to integrate, share, and analyze cancer treatment data for research community FARMINGTON, Conn., and BOSTON, Mass., October 17, 2017 – The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to... Read more

Seven Bridges Selected To Build Groundbreaking Data Analysis Platform To Fight Pediatric Disease

August 15, 2017 New data resource center will be created with the NIH and Children’s Hospital of Philadelphia to enable pediatric research across both cancer and structural birth defects datasets for the first time BOSTON, Mass., and PHILADELPHIA, Penn., August 15, 2017 –  Seven Bridges, the biomedical data analysis company, today announced that it has been selected... Read more

Seven Bridges Brings The Simons Foundation’s Genome Diversity Project Dataset To The Cloud

April 12, 2017 CAMBRIDGE, Mass., April 12, 2017 –Seven Bridges, the biomedical data analysis company, today announced that it has made the Simons Genome Diversity Project (SGDP) dataset available for analysis by researchers via the Seven Bridges Platform. The SGDP is the largest dataset of human genetic variation ever collected, including whole genomes from 279 individuals... Read more

Seven Bridges Announces Strategic Partnership With Spatial Transcriptomics

Relationship Aims to Advance Development of Innovative Tools for Visualizing and Analyzing Gene Expression within Tissue Samples April 4, 2017 CAMBRIDGE, Mass., April 4, 2017 –Seven Bridges, the biomedical data analysis company, today announced an investment in Spatial Transcriptomics, a life sciences start-up developing innovative technology to analyze tissue samples and gene expression data in... Read more